Discovery & history

• How Khavinson’s pineal peptide program produced the AEDG tetrapeptide
• What telomeres, telomerase, and the Hayflick limit actually are
• How to read the telomerase-activation claim tier by tier
• How to weigh the cancer question, the safety gaps, and the regulatory reality

1. 01 Discovery & history From pineal extracts to a four-letter peptide free
2. 02 The molecule: AEDG chemistry Four residues, one negatively charged little peptide paid
3. 03 Telomeres & the Hayflick limit The clock at the end of every chromosome paid
4. 04 Telomerase activation: the core claim The one experiment the whole reputation rests on paid
5. 05 The pineal axis: melatonin & circadian The gland epitalon was built to influence paid
6. 06 Antioxidant, mitochondria & repair The oxidative-stress and repair side of the story paid
7. 07 Animal & human evidence From rodent lifespan tails to elderly cohorts paid
8. 08 The cancer question Telomerase, immortality, and a fair reading of the data paid
9. 09 Dosing & Administration Reading community protocols without following them paid
10. 10 Safety & side effects What is reported, what is unknown, and the market reality paid
11. 11 Comparisons & the verdict Where epitalon sits, and how to read it going forward paid
12. 12 Final exam & certification Pass the final exam to earn your specialist certificate. exam

Epitalon did not appear on its own. It came out of a decades-long Soviet and Russian program, led by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, that treated short peptides as signals capable of nudging aged tissue back toward younger behavior. The timeline below marks the beats that turned a crude gland extract into a defined four-residue molecule.

Read the timeline as a slow accumulation rather than a breakthrough moment. The extract era generated hypotheses, the 2003 cell work gave the movement its mechanistic anchor, and only recent independent studies began testing the central claim outside the founding group.

People use the words interchangeably, but they are not the same thing, and the difference matters for reading the evidence. Epithalamin is a complex peptide preparation from pineal tissue: a mixture. Epitalon is a single, defined synthetic tetrapeptide. Many of the older clinical reports actually studied epithalamin, then had their conclusions carried over to the purified peptide.

Keeping the two apart is a habit worth building now. When a study says a benefit came from epithalamin, that result belongs to a mixture and does not automatically transfer to the pure tetrapeptide, even though the marketing narrative treats them as one story.

Strip away the anti-aging framing and epitalon is a very small molecule: four amino acids in a row. The sequence is alanine, glutamate, aspartate, glycine, giving the shorthand AEDG. Click each residue below to see what it contributes; the two acidic residues in the middle give the peptide its negative charge at body pH.

Four residues is about as simple as a signaling peptide gets, and that simplicity cuts both ways. It is trivial to synthesize and to verify, but it is also easy for the body’s peptidases to chop up quickly, which is one reason the pharmacokinetics are so poorly characterized.

Before any mechanisms, here is the honest picture, sorted into four tiers from best-supported to missing. The cell-level telomerase work is the most defensible layer, the animal biomarker data sit in the middle, and the human anti-aging and lifespan claims are the weakest of all. Reading these tiers correctly, and refusing to let a lower tier borrow the confidence of a higher one, is the single most important skill this whole course teaches, so keep coming back to this page.

A handful of specific claims dominate the online conversation about epitalon. Held against the evidence tiers above, most are not flatly false so much as rounded up: a real but narrow finding gets inflated into a sweeping promise. Tap each claim to see the honest verdict and its evidence tier.

Notice the pattern across the four rows: the further a claim moves from a dish and toward a whole living human, the thinner the evidence gets. That is not cynicism, it is how aging science works, and it is exactly why the cancer hallmarks framework urges caution about anything that touches telomerase.